Cytek Biosciences, Inc. CTKB Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesCurrent.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s accrued expenses?
- Cytek Biosciences, Inc. (CTKB) reported accrued expenses of $22.17M in Q1 2026.
- How has Cytek Biosciences, Inc.'s accrued expenses changed year-over-year?
- Cytek Biosciences, Inc.'s accrued expenses increased by 72.7% year-over-year, from $12.84M to $22.17M.
- What is the long-term trend for Cytek Biosciences, Inc.'s accrued expenses?
- Over 5 years (2020 to 2025), Cytek Biosciences, Inc.'s accrued expenses has grown at a 29.7% compound annual growth rate (CAGR), from $4.63M to $16.98M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.